Elevated levels of soluble tumor necrosis factor receptors are associated with increased mortality rates in patients who undergo operation for ruptured abdominal aortic aneurysm

Journal of Vascular Surgery

Volumn 31, Issue 3, 2000, Pages 514-519

  Adam, Donald J ^a   Lee, Amanda J ^b   Ruckley, C Vaughan ^a   Bradbury, Andrew W ^a   Ross, James A ^a  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR RECEPTOR;

ABDOMINAL AORTA ANEURYSM; ANEURYSM RUPTURE; ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC VALUE; HUMAN; PRIORITY JOURNAL; SURGICAL MORTALITY; SURGICAL RISK;

EID: 0034099213     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1067/mva.2000.102590     Document Type: Article

References (29)

1. Davies MG, Hagen P-O. Systemic mflammatory response syndrome. Br J Surg 1997;84:920-35.
2. Barros D'Sa AAB, Soong CV. Multiple organ dysfunction syndrome in abdominal aortic aneurysm repair. In: Greenhalgh RM, Powell JT, editors. Inflammatory and thrombotic problems in vascular surgery. London: WB Saunders; 1997. p. 129-43.
3. Sherry B, Cerami A. Cachectin/tumor necrosis factor exerts endocrine, paracrine, and autocrine control of inflammatory responses. J Cell Biol 1988;107:1269-77.
4. Shapiro L, Clark BD, Orencole SF, Poutsiaka DD, Granowitz EV, Dinarello CA. Detection of tumour necrosis factor soluble receptor p55 in blood samples from healthy and endotoxemic humans. J Infect Dis 1993;167:1344-50.
5. Tartaglia LA, Goeddel DV. Two TNF receptors. Immunol Today 1992;90:533-6.
6. Spinas GA, Keller U, Brockhaus M. Release of soluble receptors for tumor necrosis factor (TNF) in relation to circulating TNF during experimental endotoxinemia. J Clin Invest 1992;90:533-6.
7. Aderka D, Engelmann H, Maor Y, Brakebusch C, Wallach D. Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors. J Exp Med 1992;175:323-9.
8. Soong CV, Blair PH, Halliday MI, et al. Endotoxaemia, the generation of cytokines and their relationship to intramucosal acidosis of the sigmoid colon in elective abdominal aortic aneurysm repair. Eur J Vasc Endovasc Surg 1993;7:534-9.
9. Cable A, Farkas J-C, Fitting C, et al. High levels of portal TNF-α during abdominal aortic surgery. Cytokine 1993; 5:448-53.
10. Roumen RMH, Hendriks T, van der Ven-Jongekrijg J, et al. Cytokine patterns in patients after major vascular surgery, hemorrhagic shock and severe blunt trauma: relation with subsequent adults respiratory distress syndrome and multiple organ failure. Ann Surg 1993;218:769-76.
11. Thompson MM, Nasim A, Sayers RD, et al. Oxygen free radical and cytokine generation during endovascular and conventional aneurysm repair. Eur J Vasc Endovasc Surg 1996;12:70-5.
12. Foulds S, Cheshire NJ, Schachter M, Wolfe JH, Mansfield AO. Endotoxin related early neutrophil activation is associated with outcome after thoracoabdominal aortic aneurysm repair. Br J Surg 1997;84:172-7.
13. Groeneveld ABJ, Raijmakers PGHM, Rauwerda JA, Hack CE. The inflammatory response to vascular surgery-associated ischemia and reperfusion in man: effect on postoperative pulmonary function. Eur J Vasc Endovasc Surg 1997;14:351-9.
14. Barry MC, Kelly C. Burke P, Sheehan S, Redmond HP, Bouchier-Hayes D. Immunological and physiological responses to aortic surgery: effect of reperfusion on neutrophil and monocyte activation and pulmonary function. Br J Surg 1997;84:513-9.
15. Parsson HN, Nassberger L, Norgren L. Inflammatory response to aorto-bifemoral graft surgery. Int Angiol 1997; 16:55-64.
16. Froon AHM, Greve J-WM, van der Linden CJ, Buurman WA. Increased concentrations of cytokines and adhesion molecules in patients after repair of abdominal aortic aneurysm. Eur J Surg 1996;162:287-96.
17. Soong CV, Halliday MI, Barclay GR, Hood JM, Rowlands BJ, Barros D'Sa AAB. Intramucosal acidosis and systemic host responses in abdominal aortic aneurysm surgery. Crit Care Med 1997;25:1472-9.
18. Tassiopoulos AK, Carlin RE, Gao Y, et al. Role of nitric oxide and tumor necrosis factor on lung injury caused by ischemia/reperfusion of the lower extremities. J Vasc Surg 1997;26:647-56.
19. Goldie AS, Fearon KCH, Ross JA, et al. Natural cytokine antagonists and endogenous antiendotoxin core antibodies in sepsis syndrome. JAMA 1995;274;172-7.
20. De Beaux AC, Goldie AS, Ross JA, Carter DC, Fearon KCH. Serum concentrations of inflammatory mediators related to organ failure in patients with acute pancreatitis. Br J Surg 1996;83:349-53.
21. Ertel W, Keel M, Bonacchio M, et al. Release of anti-inflammatory mediators following mechanical trauma correlates with severity of injury and clinical outcome. J Trauma 1995; 39:879-87.
22. Leeuwenberg JFM, Jeunhomme GMMA, Buurman WA. Slow release of soluble TNF-receptors by monocytes in vitro. J Immunol 1994;152:4036-43.
23. Siegel S, Castellan NJ, editors. Non-parametric statistics for the behavioral sciences. New York: McGraw-Hill; 1988. p. 206-16.
24. Keel M, Ecknauer E, Stocker R, et al. Different pattern of local and systemic release of pro-inflammatory and antiinflammatory mediators in severely injured patients with chest trauma. J Trauma 1996;40:907-14.
25. Abraham E, Glauser MP, Butler T, et al. P55 tumor necrosis factor receptor fusion in the treatment of patients with severe sepsis and septic shock: a randomized controlled multicenter trial. JAMA 1997;277:1531-8.
26. Fisher CJ, Agosti JM, Opal SM, et al. Treatment of septic shock with the tumor necrosis factor receptor: Fc fusion protein: the Soluble TNF Receptor Sepsis Study Group. N Engl J Med 1996;334:1697-702.
27. Welbourn R, Goldman G, O'Riordain M, et al. Role for tumor necrosis factor as mediator of lung injury following lower torso ischemia. J Appl Physiol 1991;70:2645-9.
28. Sternbergh WC III, Tuttle TM, Makhoul RG, Bear HD, Sobel M, Fowler AA III. Postischemic extremities exhibit immediate release of tumor necrosis factor. J Vasc Surg 1994;20:474-81.
29. Hale KK, Smith CG, Baker SL, et al. Multifunctional regulation of the biological effects of TNF-alpha by the soluble type I and type II TNF receptors. Cytokine 1995;7:26-38.